| Old Articles: <Older 5041-5050 Newer> |
 |
Pharmaceutical Executive August 1, 2008 Mason Tenaglia et al. |
Inside the Doughnut Hole An answer to your question: What does the Part D coverage gap do to drug sales?  |
Pharmaceutical Executive August 1, 2008 |
Harbingers of Change The pharmaceutical industry is changing. Here are eight seminal events that describe how.  |
Pharmaceutical Executive August 1, 2008 William Schiemann |
Do Something! Seven steps you never knew that could fix the sales force.  |
Pharmaceutical Executive August 1, 2008 George Koroneos |
Hard of (Ad)hering Companies have responded to declining profits with a proliferation of patient compliance programs. But where is pharma in this paradigm shift?  |
Pharmaceutical Executive August 1, 2008 Marjorie Martin |
All Aboard! What's it going to take for pharma to get on board Web 2.0 and depart from the "selling and telling" approach?  |
Pharmaceutical Executive August 1, 2008 Gayle Lorenzi et al. |
Spanning the Treatment Gap How a diabetes field team helped docs overcome the treatment gap.  |
Pharmaceutical Executive August 1, 2008 Carol Krugman |
Next Generation Event Consolidations The path from chaos to compliance is consolidation.  |
Pharmaceutical Executive August 1, 2008 Jill Wechsler |
Can Sentinel Save Drug Development? FDA's new sentinel system shows the pendulum swing toward safety won't swing back anytime soon.  |
Pharmaceutical Executive August 1, 2008 Patrick Clinton |
Salute to the Murines What can we say about modern medicine? The answer, of course, is that it's brilliant at curing the ailments of mice.  |
Pharmaceutical Executive August 1, 2008 Sarah Houlton |
Jumping the Gun The Association of the British Pharmaceutical Industry and the British government have come up with a solution for price regulation that isn't as bad as the industry had feared.  |
| <Older 5041-5050 Newer> Return to current articles. |